Hemodynamic and tubular changes induced by contrast media

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Caiazza, Antonella ^a   Russo, Luigi ^a   Sabbatini, Massimo ^a   Russo, Domenico ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CAPTOPRIL; CONTRAST MEDIUM; DIATRIZOATE; DIURETIC AGENT; IODINATED CONTRAST MEDIUM; IODINE; IODIXANOL; IOHEXOL; IOPROMIDE; IOTALAMIC ACID; IOTROLAN; IOXAGLIC ACID; NIFEDIPINE; REACTIVE OXYGEN METABOLITE; IODINE DERIVATIVE;

ACUTE KIDNEY FAILURE; APOPTOSIS; ATHEROSCLEROSIS; CELL FUNCTION; CELL HYPOXIA; CELL TRANSPORT; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DRUG CYTOTOXICITY; ENDOTHELIAL DYSFUNCTION; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HOSPITAL PATIENT; HUMAN; KIDNEY BLOOD FLOW; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; NEPHROTOXICITY; NONHUMAN; PHYSICAL CHEMISTRY; PRACTICE GUIDELINE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TUBULAR DYSFUNCTION; VASCULARIZATION; VASOCONSTRICTION; VASODILATATION; ANIMAL; CHEMICALLY INDUCED; KIDNEY TUBULE; PATHOLOGY; PATHOPHYSIOLOGY;

ACUTE KIDNEY INJURY; ANIMALS; CONTRAST MEDIA; HEMODYNAMICS; HUMANS; IODINE COMPOUNDS; KIDNEY TUBULES;

EID: 84896291434     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/578974     Document Type: Review

References (51)

1. Russo D., Testa A., Della Volpe L., Sansone G., Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron 1990 55 3 254 257 2-s2.0-0025290157 (Pubitemid 20209507)
2. Barrett B. J., Carlisle E. J., Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993 188 1 171 178 2-s2.0-0027301087 (Pubitemid 23183119)
3. Rudnick M. R., Goldfarb S., Wexler L., Ludbrook P. A., Murphy M. J., Halpern E. F., Hill J. A., Winniford M., Cohen M. B., VanFossen D. B., Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney International 1995 47 1 254 261 2-s2.0-0028936849
4. Nash K., Hafeez A., Hou S., Hospital-acquired renal insufficiency. American Journal of Kidney Diseases 2002 39 5 930 936 2-s2.0-0036242067 10.1053/ajkd.2002.32766 (Pubitemid 34454211)
5. Stolker J. M., McCullough P. A., Rao S., Inzucchi S. E., Spertus J. A., Maddox T. M., Masoudi F. A., Xiao L., Kosiborod M., Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography. Journal of the American College of Cardiology 2010 55 14 1433 1440 2-s2.0-77949908191 10.1016/j.jacc.2009.09.072
6. Keaney J., Hannon C., Murray P., Contrast-induced acute kidney injury: how much contrast is safe? Nephrology Dialysis Transplantation 2013 28 1376 1383
7. Rihal C. S., Textor S. C., Grill D. E., Berger P. B., Ting H. H., Best P. J., Singh M., Bell M. R., Barsness G. W., Mathew V., Garratt K. N., Holmes D. R. Jr., Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002 105 19 2259 2264 2-s2.0-0037076345 10.1161/01.CIR.0000016043.87291.33 (Pubitemid 34535335)
8. Heyman S. N., Rosenberger C., Rosen S., Experimental ischemia- reperfusion: biases and mythsthe proximal vs. distal hypoxic tubular injury debate revisited. Kidney International 2010 77 1 9 16 2-s2.0-72949089927 10.1038/ki.2009.347
9. Lameire N., Vanholder R., Pathophysiologic features and prevention of human and experimental acute tubular necrosis. Journal of the American Society of Nephrology 2001 12 17 S20 S32 2-s2.0-0035140881 (Pubitemid 32119050)
10. Fliser D., Laville M., Covic A., A European renal best practice (ERBP) position statement on the kidney disease improving global outcomes (KDIGO) clinical practice Guidelines on acute kidney injury: part 1 definitions, conservative management and contrast induced nephropathy. Nephrology Dialysis Transplantation 2012 27 4263 4272
11. Neyra J., Shah S., Mooney R., Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease. Nephrology Dialysis Transplantation 2013 28 1463 1471
12. Jo S.-H., Youn T.-J., Koo B.-K., Park J.-S., Kang H.-J., Cho Y.-S., Chung W.-Y., Joo G.-W., Chae I.-H., Choi D.-J., Oh B.-H., Lee M.-M., Park Y.-B., Kim H.-S., Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography. the recover study: a randomized controlled trial. Journal of the American College of Cardiology 2006 48 5 924 930 2-s2.0-33748202601 10.1016/j.jacc.2006.06.047 (Pubitemid 44308573)
13. McCullough P. A., Bertrand M. E., Brinker J. A., Stacul F., A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. Journal of the American College of Cardiology 2006 48 4 692 699 2-s2.0-33644768605 10.1016/j.jacc.2006.02.073 (Pubitemid 44175706)
14. Solomon R. J., Mehran R., Natarajan M. K., Doucet S., Katholi R. E., Staniloae C. S., Sharma S. K., Labinaz M., Gelormini J. L., Barrett B. J., Contrast-induced nephropathy and long-term adverse events: cause and effect? Clinical Journal of the American Society of Nephrology 2009 4 7 1162 1169 2-s2.0-66149188637 10.2215/CJN.00550109
15. Solomon R. J., Natarajan M. K., Doucet S., Sharma S. K., Staniloae C. S., Katholi R. E., Gelormini J. L., Labinaz M., Moreyra A. E., Cardiac angiography in renally impaired patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 2007 115 25 3189 3196 2-s2.0-34347345064 10.1161/CIRCULATIONAHA.106. 671644 (Pubitemid 47012233)
16. Heinrich M. C., Häberle L., Müller V., Bautz W., Uder M., Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 2009 250 1 68 86 2-s2.0-58149331038 10.1148/radiol.2501080833
17. Liss P., Persson P. B., Hansell P., Lagerqvist B., Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney International 2006 70 10 1811 1817 2-s2.0-33750584032 10.1038/sj.ki.5001887 (Pubitemid 44684813)
18. Kidney disease: improving global outcomes (KDIGO), Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury 2012 2 Kidney International Supplements
19. Okusa M., Devenport A., Reading between the (guide)lines- the KDIGO practice guideline on acute kidney injury in the individual patient. Kidney International 2013 10.1038/ki.2013.378
20. Cigarroa R. G., Lange R. A., Williams R. H., Hillis L. D., Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. American Journal of Medicine 1989 86 6 649 652 2-s2.0-0024392252 (Pubitemid 19149343)
21. Stacul F., van der Molen A. J., Reimer P., Webb J. A. W., Thomsen H. S., Morcos S. K., Almén T., Aspelin P., Bellin M.-F., Clement O., Heinz-Peer G., Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines. European Radiology 2011 21 12 2527 2541 2-s2.0-83555173218 10.1007/s00330-011-2225-0
22. Dong M., Jiao Z., Liu T., Guo F., Li G., Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controlled trials. Journal of Nephrology 2012 25 290 293
23. Karlsberg R. P., Dohad S. Y., Sheng R., Contrast mediuminduced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium. Journal of Vascular and Interventional Radiology 2011 22 8 1159 1165 2-s2.0-79960901953 10.1016/j.jvir.2011.03.020
24. Kooiman J., Le Haen A. P., Gezgin G., Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. American Heart Journal 2013 165 793 799
25. Caldicott W. J., Hollenberg N. K., Abrams H. L., Characteristics of response of renal vascular bed to contrast media. Evidence for vasoconstriction induced by renin-angiotensin system. Investigative Radiology 1970 5 6 539 547 2-s2.0-0014879965
26. Katzberg R. W., Schulman G., Meggs L. G., Mechanism of the renal response to contrast medium in dogs. Decrease in renal function due to hypertonicity. Investigative Radiology 1983 18 1 74 80 2-s2.0-0020677257 (Pubitemid 13187431)
27. Liss P., Nygren A., Olsson U., Ulfendahl H. R., Erikson U., Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney. Kidney International 1996 49 5 1268 1275 2-s2.0-0029889465 (Pubitemid 26167278)
28. Liss P., Nygren A., Erikson U., Ulfendahl H. R., Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney International 1998 53 3 698 702 2-s2.0-0031915941 10.1046/j.1523-1755. 1998.00811.x (Pubitemid 28124285)
29. Bankir L., Kriz W., Goligorsky M., Nambi P., Thomson S., Blantz R. C., Vascular contributions to pathogenesis of acute renal failure. Renal Failure 1998 20 5 663 677 2-s2.0-0031681427 (Pubitemid 28413223)
30. Bakris G. L., Burnett J. C. Jr., A role for calcium in radiocontrast-induced reductions in renal hemodynamics. Kidney International 1985 27 2 465 468 2-s2.0-0021945823 (Pubitemid 15142702)
31. Russo D., Minutolo R., Cianciaruso B., Memoli B., Conte G., De Nicola L., Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. Journal of the American Society of Nephrology 1995 6 5 1451 1458 2-s2.0-0028791280
32. Neumayer H.-H., Junge W., Kufner A., Wenning A., Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial. Nephrology Dialysis Transplantation 1989 4 12 1030 1036 2-s2.0-0024938617 (Pubitemid 20135461)
33. Cacoub P., Deray G., Baumelou A., Jacobs C., No evidence for protective effects of nifedipine against radiocontrast-induced acute renal failure. Clinical Nephrology 1988 29 4 215 216 2-s2.0-0023992950
34. Khoury Z., Schlicht J. R., Como J., Karschner J. K., Shapiro A. P., Mook W. J., Weber R. J., The effect of prophylactic nifedipine on renal function in patients administered contrast media. Pharmacotherapy 1995 15 1 59 65 2-s2.0-0028890871
35. Dangas G., Iakovou I., Nikolsky E., Aymong E. D., Mintz G. S., Kipshidze N. N., Lansky A. J., Moussa I., Stone G. W., Moses J. W., Leon M. B., Mehran R., Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. American Journal of Cardiology 2005 95 1 13 19 2-s2.0-19944398728 10.1016/j.amjcard.2004.08.056 (Pubitemid 40051105)
36. Larson T. S., Hudson K., Mertz J. I., Renal vasoconstrictive response to contrast medium. The role of sodium balance and the renin-angiotensin system. Journal of Laboratory and Clinical Medicine 1983 101 3 385 391 2-s2.0-0020696423 (Pubitemid 13164264)
37. Gupta R. K., Kapoor A., Tewari S., Sinha N., Sharma R. K., Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. Indian Heart Journal 1999 51 5 521 526 2-s2.0-0033509991 (Pubitemid 30139601)
38. El-Harakeeh M. A., Kleiner M., Ahern K., Effects of chronic angiotensin receptor blockers and ACE inhibitors use on the incidence of contrast induces nephropathy in patients with chronic renal insufficiency. Journal of the American Society of Nephrology A 2004 15, article 341
39. Cirit M., Toprak O., Yesil M., Bayata S., Postaci N., Pupim L., Esi E., Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron 2006 104 1 c20 c27 2-s2.0-33747075921 10.1159/000093255
40. Pannu N., Nadim M. K., An overview of drug-induced acute kidney injury. Critical Care Medicine 2008 36 4 S216 S223 2-s2.0-41649087623 10.1097/CCM.0b013e318168e375 (Pubitemid 351483055)
41. Kiski D., Stepper W., Brand E., Breithardt G., Reinecke H., Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial. Nephrology Dialysis Transplantation 2010 25 3 759 764 2-s2.0-77649200557 10.1093/ndt/gfp582
42. Tervahartiala P., Structural changes in the renal proximal tubular cells induced by iodinated contrast media. Studies in dehydrated rats. Nephron 1997 76 1 96 102 2-s2.0-0031004563 (Pubitemid 27199046)
43. Li X., Li T., Cong H., Is Angiotensin-converting enzyme inhibitor a contraindication for contrast-induced nephropathy prophylaxis? A review about its paradox. Cardiovascular Therapeutics 2012 30 273 276 2-s2.0-81155157396 10.1111/j.1755-5922.2011.00299.x
44. Bachorzewska-Gajewska H., Malyszko J., Sitniewska E., Malyszko J. S., Dobrzycki S., Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. American Journal of Nephrology 2006 26 3 287 292 2-s2.0-33746414787 10.1159/000093961 (Pubitemid 44121091)
45. Bachorzewska-Gajewska H., Malyszko J., Sitniewska E., Malyszko J. S., Dobrzycki S., Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography [19]. Nephrology Dialysis Transplantation 2007 22 1 295 296 2-s2.0-33846012877 10.1093/ndt/gfl408 (Pubitemid 46050378)
46. Andreucci M., Faga T., Russo D., Differential activation of signaling pathways by low-osmolar and iso-osmolar radiocontrast agents in human renal proximal tubular cells. Journal of Cellular Biochemistry 2014 115 281 289
47. Hirsch R., Dent C., Pfriem H., Allen J., Beekman R. H. III, Ma Q., Dastrala S., Bennett M., Mitsnefes M., Devarajan P., NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatric Nephrology 2007 22 12 2089 2095 2-s2.0-36048965159 10.1007/s00467-007-0601-4 (Pubitemid 350090716)
48. Nickolas T. L., Barasch J., Devarajan P., Biomarkers in acute and chronic kidney disease. Current Opinion in Nephrology and Hypertension 2008 17 2 127 132 2-s2.0-39149134872 10.1097/MNH.0b013e3282f4e525 (Pubitemid 351253035)
49. Ling W., Zhaohui N., Ben H., Leyi G., Jianping L., Huili D., Jiaqi Q., Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron 2008 108 3 c176 c181 2-s2.0-42549104621 10.1159/000117814 (Pubitemid 351588109)
50. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A., Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. American Journal of Kidney Diseases 2009 54 6 1012 1024 2-s2.0-70449637194 10.1053/j.ajkd.2009.07.020
51. Andreucci M., Fuiano G., Presta P., Esposito P., Faga T., Bisesti V., Procino A., Altieri V., Tozzo C., Memoli B., Michael A., Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells. Biochemical Pharmacology 2006 72 10 1334 1342 2-s2.0-33750201137 10.1016/j.bcp.2006.08.008 (Pubitemid 44604287)